Wednesday, July 8, 2026

biotech · Amyotrophic Lateral Sclerosis (ALS) · Amyotrophic Lateral Sclerosis · BCLI

BRAINSTORM CELL THERAPEUTICS

News and analysis for BRAINSTORM CELL THERAPEUTICS on NovaPharmaNews — regulatory, clinical, and market coverage.

NEW YORK, NY, USA HQ
2004 Founded
30 Employees
Public company Type
BCLI · NYSE Ticker
Company details
Status
Public
HQ
NEW YORK, NY, USA
Founded
2004
Employees
30
Programs
5
Drugs
5
Patents
8
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning BRAINSTORM CELL THERAPEUTICS — regulatory, clinical, and market coverage.

News and analysis for BRAINSTORM CELL THERAPEUTICS on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning BRAINSTORM CELL THERAPEUTICS yet.

Back to company overview →